The present study investigated pro-fibrotic effect of LRP5 in CKD models such as diabetes and UUO, and identified a new role of LRP5 in regulating the TGF-β/Smad signaling pathway to promote renal fibrosis. Here, TGFB1 is linked to chronic kidney disease.